GENE ONLINE|News &
Opinion
Blog

2025-12-02|

ACIP to Review Hepatitis B Vaccine Guidelines and Childhood Immunization Schedule Amid Controversy Over Chair’s COVID-19 Vaccine Claims

by GOAI
Share To

The Advisory Committee on Immunization Practices (ACIP) is set to meet this week to discuss updates to the hepatitis B vaccine recommendations and the childhood immunization schedule. The meeting will be chaired by Dr. Kirk Milhoan, a physician and pastor who has recently made claims regarding COVID-19 vaccines, alleging they contain contaminants linked to cancer.

Dr. Milhoan’s statements about COVID-19 vaccines have drawn attention ahead of the ACIP meeting. Despite these remarks, the committee plans to focus on reviewing current vaccination guidelines, including potential changes to hepatitis B protocols and updates to the recommended immunization schedule for children. The discussions aim to address public health priorities related to vaccine-preventable diseases.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Zai Lab Presents Preclinical Data on ZL-1503 Targeting IL-13 and IL-31Rα for Itch Relief and Inflammation Reduction in Atopic Diseases
2026-04-18
Study Reveals Temporal Changes in Human Milk Oligosaccharide Profiles and Their Impact on Infant Health
2026-04-18
Parkinson’s Disease Proteins Found to Weaken Blood-Brain Barrier, Study Shows
2026-04-18
Barriers to Immunity Research Identified in Long-Term Care and Retirement Homes Study
2026-04-18
Study Reveals Variability in PD-L1 Combined Positive Score Application Between Clinical Trials and Real-World Settings for Gastroesophageal Cancer
2026-04-18
Study Identifies RIPK1/RIPK3-MLKL Pathway as Target to Reduce Preterm Births
2026-04-18
Low-Temperature Drying and Airtight Packaging Found Effective for Preserving Nutrients in Bauhinia Purpurea Petals
2026-04-18
Scroll to Top